It is more difficult than ever to secure funding to develop new products through the usual channels. With a vital need for alternative solutions, New Paradigms is the only event to help you find new sources to fund your product development, as well as develop an effective strategy to define and communicate proof of mechanism to your stakeholders. by Dr Sandra Garrett, Executive Chair, GRS and Dr Peter Milner, Co-founder of CVT, ARYx and Optivia, New Paradigms has attracted a speaking faculty of over 40 professionals, including some of the most influential leaders from the biotech, pharmaceutical and investment communities.
As a business development conference, rather than a partnering event, this program is a wonderful complement to the JP Morgan conference. It allows you to learn in a relaxed environment from professionals who have succeeded in developing products using an alternative source of funding. Networking is built into the conference with scheduled breaks, a luncheon and reception.

This conference is designed for senior-level Biotech, Pharmaceutical, Drug Delivery and CRO executives with responsibilities in Strategy, Financial Transactions and R&D. This conference is also beneficial to investors. •Biotech •Pharmaceutical •Drug Delivery •CROs •Investors